COM:AUTOLUS
Autolus Therapeutics plc
- Stock
Last Close
2.84
22/11 21:00
Market Cap
1.05B
Beta: -
Volume Today
1.60M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '16 | Sep '17 | Sep '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|
average inventory | 1.10M - | 5.01M 353.71% | -10.94M 318.36% | -9.78M 10.58% | 12.14M 224.12% | ||||
average payables | 1.69M - | 7.23M 327.40% | 6.80M 6.02% | 1.67M 75.44% | 1.35M 19.29% | 481K 64.29% | |||
average receivables | 3.46M - | 5.77M 67.00% | 18.67M 223.52% | 30.10M 61.28% | 27.97M 7.10% | 27.61M 1.27% | |||
book value per share | 2.23 - | 10.35 364.70% | 6.50 37.17% | 5.92 8.97% | 4.07 31.16% | 4.35 6.70% | 3.14 27.66% | ||
capex per share | -0.13 - | -0.21 55.04% | -0.28 33.21% | -0.43 55.95% | -0.28 34.31% | -0.12 56.85% | -0.11 7.12% | ||
capex to depreciation | -3.88 - | -2.85 26.55% | -7.94 178.49% | -4.05 49.00% | -2.59 35.91% | -1.05 59.64% | -1.46 39.49% | ||
capex to operating cash flow | 0.19 - | 0.18 6.66% | 0.34 93.04% | 0.18 45.79% | 0.12 32.23% | 0.08 39.72% | 0.10 28.45% | ||
capex to revenue | -1.53 - | -1.70 10.99% | -8.39 393.94% | -6.42 23.49% | -60.67 845.01% | -3.80 93.73% | -1.75 53.96% | ||
cash per share | 2.04 - | 9.94 388.51% | 6.00 39.68% | 4.89 18.46% | 2.97 39.21% | 4.31 44.79% | 4.03 6.49% | ||
days of inventory on hand | -2.23K - | ||||||||
days payables outstanding | -12.63K - | ||||||||
days sales outstanding | 656.22 - | 1.02K 55.43% | 2.38K 133.08% | 3.83K 61.16% | 44.77K 1,068.62% | 4.11K 90.82% | 1.71K 58.48% | ||
debt to assets | 0.01 - | 0.00 67.59% | 0.00 43.04% | 0.09 8,407.91% | 0.18 113.08% | 0.05 71.87% | 0.05 4.44% | ||
debt to equity | 0.01 - | 0.00 69.67% | 0.00 42.03% | 0.10 9,450.81% | 0.26 150.62% | 0.07 74.01% | 0.08 21.18% | ||
dividend yield | |||||||||
earnings yield | -0.04 - | -0.06 57.19% | -0.03 43.79% | -0.22 577.03% | -0.31 41.50% | -0.38 23.21% | -0.82 117.12% | -0.19 77.44% | |
enterprise value | 316.71M - | 207.78M 34.40% | 777.83M 274.36% | 384.04M 50.63% | 361.79M 5.79% | 84.78M 76.57% | -177.69M 309.60% | ||
enterprise value over ebitda | -22.79 - | -9.27 59.31% | -22.09 138.26% | -2.88 86.95% | -2.23 22.75% | -0.54 75.55% | 1.14 308.78% | ||
ev to operating cash flow | -32.16 - | -12.70 60.50% | -30.09 136.95% | -3.78 87.42% | -3.07 18.81% | -0.72 76.59% | 1.58 319.97% | ||
ev to sales | 261.31 - | 122.73 53.03% | 744.09 506.30% | 132.06 82.25% | 1.50K 1,032.03% | 36.38 97.57% | -28.69 178.85% | ||
free cash flow per share | -0.85 - | -1.40 64.35% | -1.10 21.39% | -2.79 154.32% | -2.57 7.93% | -1.76 31.56% | -1.30 26.25% | ||
free cash flow yield | -0.03 - | -0.06 64.35% | -0.04 35.86% | -0.21 490.34% | -0.29 35.94% | -0.34 17.88% | -0.68 101.44% | ||
graham net net | 1.90 - | 9.76 413.57% | 5.80 40.60% | 4.38 24.42% | 1.48 66.14% | 3.37 127.01% | 2.31 31.37% | ||
graham number | 6.75 - | 18.25 170.27% | 12.01 34.21% | 19.57 62.94% | 15.89 18.78% | 13.88 12.64% | 10.53 24.17% | ||
income quality | 0.78 - | 0.83 5.68% | 0.83 0.17% | 0.82 1.36% | 0.83 1.14% | 0.83 0.09% | 0.75 9.03% | ||
intangibles to total assets | 0 - | 0 | 0.04 Infinity% | 0.00 98.04% | 0.00 35.83% | 0.00 70.15% | 0 100% | 0 | |
interest coverage | 293.39 - | 616.26 110.05% | -4.54K 837.02% | -148.60 - | -18.39 87.62% | ||||
interest debt per share | 0.01 - | 0.02 63.31% | 0.01 55.04% | 0.61 8,122.77% | 1.05 72.53% | 0.31 70.81% | 0.35 13.85% | ||
inventory turnover | -0.16 - | ||||||||
invested capital | 0.01 - | 0.00 69.67% | 0.00 42.03% | 0.10 9,450.81% | 0.26 150.62% | 0.07 74.01% | 0.08 21.18% | ||
market cap | 344.58M - | 344.58M 0% | 966.91M 180.60% | 568.47M 41.21% | 460.93M 18.92% | 374.12M 18.83% | 180.49M 51.76% | 1.12B 520.64% | |
net current asset value | 27.43M - | 136.42M 397.29% | 186.63M 36.80% | 200.56M 7.47% | 112.78M 43.77% | 254.71M 125.85% | 234.17M 8.06% | ||
net debt to ebitda | 2.01 - | 6.10 204.42% | 5.37 12.04% | 1.38 74.23% | 0.61 55.92% | 1.86 204.48% | 2.29 23.31% | ||
net income per share | -0.91 - | -1.43 57.19% | -0.99 31.11% | -2.88 191.67% | -2.76 4.17% | -1.97 28.47% | -1.57 20.52% | -1.20 23.54% | |
operating cash flow per share | -0.71 - | -1.19 66.11% | -0.82 30.99% | -2.36 187.71% | -2.28 3.08% | -1.64 28.41% | -1.18 27.69% | ||
payables turnover | -0.03 - | ||||||||
receivables turnover | 0.56 - | 0.36 35.66% | 0.15 57.10% | 0.10 37.95% | 0.01 91.44% | 0.09 988.80% | 0.21 140.83% | ||
research and ddevelopement to revenue | 8.61 - | 9.46 9.84% | 23.57 149.20% | 36.25 53.81% | 557.39 1,437.58% | 57.85 89.62% | 22.92 60.37% | 76.84 235.21% | |
return on tangible assets | -0.37 - | -0.13 63.86% | -0.15 12.53% | -0.41 173.47% | -0.48 18.32% | -0.35 27.48% | -0.30 13.37% | ||
revenue per share | 0.09 - | 0.12 39.69% | 0.03 73.03% | 0.07 103.85% | 0.00 93.05% | 0.03 588.65% | 0.07 101.73% | 0.01 85.03% | |
roe | -0.41 - | -0.14 66.17% | -0.15 9.64% | -0.49 220.42% | -0.68 39.21% | -0.45 32.96% | -0.50 9.88% | ||
roic | -0.41 - | -0.14 66.09% | -0.24 73.31% | -0.40 66.76% | -0.45 12.93% | -0.40 12.36% | -0.41 2.47% | ||
sales general and administrative to revenue | 4.25 - | 5.37 26.43% | 16.12 199.84% | 13.57 15.81% | 144.51 965.20% | 13.68 90.54% | 5.15 62.34% | ||
shareholders equity per share | 2.23 - | 10.35 364.70% | 6.50 37.17% | 5.92 8.97% | 4.07 31.16% | 4.35 6.70% | 3.14 27.66% | ||
stock based compensation to revenue | 1.86 - | 1.86 0.01% | 4.81 158.20% | 10.39 116.05% | 83.09 699.74% | 4.26 94.87% | 1.94 54.52% | ||
tangible asset value | 30.69M - | 142.60M 364.70% | 195.84M 37.34% | 254.59M 29.99% | 209.87M 17.56% | 313.25M 49.26% | 298.67M 4.65% | ||
tangible book value per share | 2.23 - | 10.35 364.70% | 6.21 40.01% | 5.91 4.74% | 4.07 31.14% | 4.35 6.76% | 3.14 27.65% | ||
working capital | 28.19M - | 137.45M 387.56% | 186.63M 35.78% | 224.27M 20.17% | 163.35M 27.16% | 318.40M 94.92% | 379.40M 19.16% |
All numbers in USD (except ratios and percentages)